| Curcumin and Ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cells D Kumar, S Basu, L Parija, D Rout, S Manna, J Dandapat, PR Debata Biomedicine & pharmacotherapy 81, 31-37, 2016 | 102 | 2016 |
| Blue-emitting copper-doped zinc oxide nanocrystals R Viswanatha, S Chakraborty, S Basu, DD Sarma The Journal of Physical Chemistry B 110 (45), 22310-22312, 2006 | 91 | 2006 |
| Self-adaptive Topology Management For Mobile Ad-hoc Network AC S S Basu Journal of The Institution of Engineers (India) 84, pp 7-13, 2003 | 37 | 2003 |
| Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to … KB Lokhande, S Ballav, RS Yadav, KV Swamy, S Basu Journal of Biomolecular Structure and Dynamics 40 (3), 971-981, 2022 | 36 | 2022 |
| Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule … KB Lokhande, S Ballav, N Thosar, KV Swamy, S Basu Journal of Molecular Modeling 26, 1-12, 2020 | 22 | 2020 |
| Self-adaptive MANET: a centralized approach SS Basu, A Chaudhuri Foundations of Computing and Decision Sciences 29 (4), 271-286, 2004 | 19 | 2004 |
| Drug repurposing—an emerging strategy in cancer therapeutics KS Turabi, A Deshmukh, S Paul, D Swami, S Siddiqui, U Kumar, S Naikar, ... Naunyn-Schmiedeberg's Archives of Pharmacology 395 (10), 1139-1158, 2022 | 17 | 2022 |
| PPAR-γ partial agonists in disease-fate decision with special reference to cancer S Ballav, B Biswas, VK Sahu, A Ranjan, S Basu Cells 11 (20), 3215, 2022 | 15 | 2022 |
| A novel security scheme for wireless adhoc network A Das, SS Basu, A Chaudhuri 2011 2nd International Conference on Wireless Communication, Vehicular …, 2011 | 11 | 2011 |
| Energy aware topology security scheme for mobile Ad Hoc network A Das, A Rahman, SS Basu, A Chaudhuri Proceedings of the 2011 International Conference on Communication, Computing …, 2011 | 10 | 2011 |
| Designing Novel Quercetin Derivatives as Matrix Metalloproteinase-9 Inhibitors in Colon Carcinoma: An: In vitro: and: In silico: Approach S Ballav, KB Lokhande, I Dabhi, S Inje, A Ranjan, KV Swamy, S Basu Journal of Dental Research and Review 7 (Suppl 1), S30-S35, 2020 | 8 | 2020 |
| Application of Electrolysis in Recovery of Chemical from Black Liquor VS Joshi, S Basu Chemical Age of India 24 (10), 671-676, 1973 | 8 | 1973 |
| Two-dimensional and three-dimensional cell culture and their applications S Ballav, AJ Deshmukh, S Siddiqui, J Aich, S Basu Cell Culture—Advanced Technology and Applications in Medical and Life Sciences, 2021 | 6 | 2021 |
| Cu (II) complexes of hydrazones–NSAID conjugates: synthesis, characterization and anticancer activity J Kaur, T Chikate, P Bandyopadhyay, S Basu, R Chikate Journal of Coordination Chemistry 73 (23), 3186-3202, 2020 | 5 | 2020 |
| Studies on carbonation of black liquor for lignin precipitation and its subsequent separation S Basu IPPTA, Oct 8 (4), 207, 1971 | 5 | 1971 |
| Computational screening of phytochemicals for anti-cancer drug discovery KS Turabi, S Bhupal, S Layek, S Garse, S Devarajan, D Iyer, S Basu, ... Phytochemistry, Computational Tools and Databases in Drug Discovery, 313-334, 2023 | 4 | 2023 |
| A requirement framework for enablement of automatic generation of domain model A Sanyal, SS Basu, S Choudhury 2010 International Conference on Computer Information Systems and Industrial …, 2010 | 4 | 2010 |
| Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells: a computational drug discovery and in vitro insight D Swami, P Mudaliar, YS Bichu, V Kumar Sahu, S Devarajan, S Basu, ... Journal of Biomolecular Structure and Dynamics 41 (12), 5802-5816, 2023 | 3 | 2023 |
| Revisiting the Role of CD63 as Pro‐Tumorigenic or Anti‐Tumorigenic Tetraspanin in Cancers and its Theragnostic Implications S Dey, S Basu, A Ranjan Advanced Biology 7 (7), 2300078, 2023 | 3 | 2023 |
| Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer S Ballav, KB Lokhande, RS Yadav, P Ghosh, KV Swamy, S Basu Molecular Diversity 27 (6), 2867-2885, 2023 | 2 | 2023 |
